XW043C7 Introduction of Autologous Engineered Chimeric Antigen Receptor T-cell Immunotherapy into Central Vein, Percutaneous Approach, New Technology Group 7
Section: New Technology
Body system: Anatomical Regions
Operation: Introduction — Putting in or on a therapeutic, diagnostic, nutritional, physiological, or prophylactic substance except blood or blood products